USE OF 4-CHLORO-5-{2-[4-(6-FLUORO-1,2-BENZ[D]IZOXAZOL-3-YL)PIPERIDIN-1-YL]ETHYLAMINO}2-METHYL-3(2H)-PIRIDAZINON FOR THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS FOR INFLUENCING COGNITIVE FUNCTIONS AND CAUSING NEUROPROTECTIVE EFFECT

The invention relates the use of 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]isoxazole-3-yl)piperidin-1-yl]ethyl-amino}-2-methyl-3-(2H)pyridazinone of the Formula (I) or pharmaceutically acceptable salts thereof for the preparation of medicaments suitable for the improvement of cognitive function or obtai...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KERTESZ SZABOLCS DR, HARSING LASZLO GABOR DR, MORICZ KRISZTINA, GACSALYI ISTVAN, LEVAY GYOERGY DR, GIGLER GABOR, SZENASI GABOR DR, AGOSTON MARTA DR, KOMPAGNE HAJNALKA, BARKOCZI JOZSEF DR, SIMIG GYULA DR
Format:	Patent
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates the use of 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]isoxazole-3-yl)piperidin-1-yl]ethyl-amino}-2-methyl-3-(2H)pyridazinone of the Formula (I) or pharmaceutically acceptable salts thereof for the preparation of medicaments suitable for the improvement of cognitive function or obtaining neuroprotective effect. The medicaments containing 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]isoxazol-3-yl)piperidin-1-yl]ethyl-amino}-2-methyl-3-(2H)pyridazinone of the Formula (I) or therapeutically acceptable salt thereof can be used for the treatment or prevention of neuronal death, mental decline, sclerosis multiplex, Creuzfeld-Jacobs disease, Huntington-syndrome, amyotrophic lateral sclerosis, Parkinson-disease, memory disturbance, loss of memory, amnesia, stroke or for the improvement of memory function or learning ability.